The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies
Author:
Affiliation:
1. Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing, China
2. Graduate School of Chinese PLA General Hospital, Beijing, China
Funder
National Natural Science Foundations of China
Medicine Clinical Research
Publisher
Informa UK Limited
Subject
Virology,Infectious Diseases,Microbiology (medical),Microbiology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14787210.2023.2166931
Reference77 articles.
1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
2. Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
3. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach
4. Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa
5. Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection: 2024 Update;Surgical Infections;2024-08-01
2. Effectiveness of novel β-lactams for Pseudomonas aeruginosa infection: A systematic review and meta-analysis;American Journal of Infection Control;2024-07
3. Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials;Expert Review of Anti-infective Therapy;2023-10-13
4. Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic;Viruses;2023-08-30
5. New Antimicrobials for the Treatment of Neonatal Sepsis Caused by Multi-Drug-Resistant Bacteria: A Systematic Review;Antibiotics;2023-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3